Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Adesso BioProducts AB

Closing information (x1000 EUR)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 150,414 More Arrow 239,987 More Arrow 245,136
Financial expenses 615 More Arrow 1,497 Less Arrow 990
Earnings before taxes 16,147 More Arrow 18,577 Less Arrow 15,070
EBITDA 16,009 More Arrow 19,617 Less Arrow 16,161
Total assets 76,285 Less Arrow 74,595 More Arrow 81,099
Current assets 74,766 Less Arrow 73,076 More Arrow 79,501
Current liabilities 14,904 More Arrow 21,959 More Arrow 29,166
Equity capital 54,416 Less Arrow 45,427 Less Arrow 39,837
- share capital 9 Equal arrow 9 Equal arrow 9
Employees (average) 22 More Arrow 24 Less Arrow 21

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 71.3% Less Arrow 60.9% Less Arrow 49.1%
Turnover per employee 6,837 More Arrow 9,999 More Arrow 11,673
Profit as a percentage of turnover 10.7% Less Arrow 7.7% Less Arrow 6.1%
Return on assets (ROA) 22.0% More Arrow 26.9% Less Arrow 19.8%
Current ratio 501.7% Less Arrow 332.8% Less Arrow 272.6%
Return on equity (ROE) 29.7% More Arrow 40.9% Less Arrow 37.8%
Change turnover -81,415 More Arrow -5,862 More Arrow 20,308
Change turnover % -35% More Arrow -2% More Arrow 9%
Chg. No. of employees -2 More Arrow 3 Less Arrow 0
Chg. No. of employees % -8% More Arrow 14% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.